Ajinomatrix
Ajinomatrix
Established in 2018 by
BD Contact
Summary
AI-driven sensory software for the food industry, specializing in digitizing taste and smell.
Alpha Omega Engineering Ltd.
Alpha Omega Engineering Ltd.
Established in 1993 by
BD Contact
Summary
Altimmune
Altimmune
Established in 2001 by
BD Contact
Summary
AMAT (S) PTE.
AMAT (S) PTE.
Ananda Labs
Ananda Labs
Established in 2023 by
BD Contact
Summary
Ananda Labs is reversing aging-related conditions through epigenetic reprogramming. Our mission is to develop treatments that reverse aging-related diseases, rejuvenate appearance for a younger look, and improve the function of the immune system as preventive medicine.
APIX Biosciences
APIX Biosciences
Established in 2017 by
BD Contact
Summary
APIX Biosciences has been established by two of the worlds’ leading authorities on bee nutrition who seek to commercialize their work, and that of an international research team involving The Hebrew University of Jerusalem (Israel) and the Universities of Oxford and Newcastle (UK) that, after 7+ years’ work, has resulted in a new feed formulation for honeybees that is demonstrably superior to any of those presently on the market.
ATED Therapeutics
ATED Therapeutics
Established in 2024 by
BD Contact
Summary
Ayana Pharma
Ayana Pharma
Established in 2013 by
BD Contact
Summary
Ayana Pharma develops liposome-based treatments for cancer. Ayana was formed to leverage the benefits of the anticancer drug Doxil, an FDA-approved liposomal nanodrug that has been used in the treatment of ovarian cancer, metastatic breast cancer, AIDS-related Kaposi’s sarcoma, and multiple myeloma. Co-founded by one of Doxil’s co-inventors, Professor Yechezkel Barenholz from the Hebrew University, the company is working to expand its treatment uses and efficacy while making it more readily available to address a range of conditions. Ayana has completed fundraising to support an abbreviated new drug application (ANDA), filing, and commercialization.
Betalin Therapeutics
Betalin Therapeutics
Established in 2017 by
BD Contact
Summary
Revolutionizing diabetes treatment. Betalin is currently carrying pre-clinical studies and in discussions with both the Human Tissue Association (UK) and Food Drug Association (US) to begin clinical trials. Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development. Â
Better Meal
Better Meal
Summary
BeWeld Medical
BeWeld Medical
Summary
BeWeld developing revolutionary tech which enable Manufacturer of medical grafts to machined and automated their MFG
BioArmix
BioArmix
Established in 2024 by
BD Contact
Summary